Adaptimmune Therapeutics (ADAP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.56
-0.03 (-5.07%)
At close: Jan 15, 2025, 10:43 AM
ADAP Employees
Adaptimmune Therapeutics had 449 employees on Mar 6, 2024. The number of employees decreased
by -85 or
-15.92%
compared to the previous year.
Employees
449
Change (1Y)
-85
Growth (1Y)
-15.92%
Revenue / Employee
$134,256.12
Profits / Employee
-$253,610.24
Market Cap
143.86M
Employees Chart
Date | Employees | Change | Growth |
---|---|---|---|
Mar 6, 2024 | 449 | -85 | -18.93% |
Mar 6, 2023 | 534 | 40 | +7.49% |
Mar 14, 2022 | 494 | 32 | +6.48% |
Feb 25, 2021 | 462 | 62 | +13.42% |
Feb 27, 2020 | 400 | -30 | -7.50% |
Feb 27, 2019 | 430 | 59 | +13.72% |
Mar 15, 2018 | 371 | 73 | +19.68% |
Mar 13, 2017 | 298 | -202 | -67.79% |
Mar 17, 2016 | 500 | 384 | +76.80% |
Oct 13, 2015 | 116 | n/a | n/a |